M H Freedman|E F Saunders - JoVE Visualize

Showing results (141-150 of 160) with videos related to

Pageof 16

Sort By:

Blood|February 9, 1999

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approachJ Dimitroulakos, D Nohynek, K L Backway, et al.

Cancer Research|January 1, 1995

Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell linesG A Brown, J P McPherson, L Gu, et al.

Blood|December 1, 1996

Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disordersD K Miles, M H Freedman, K Stephens, et al.

Science (New York, N.Y.)|December 22, 1989

A model of human acute lymphoblastic leukemia in immune-deficient SCID miceS Kamel-Reid, M Letarte, C Sirard, et al.

Blood|September 1, 1996

Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot studyW R Rackoff, A Orazi, C A Robinson, et al.

Cancer Research|June 26, 1999

Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.

Blood|December 1, 1991

Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid miceS Kamel-Reid, M Letarte, M Doedens, et al.

Leukemia|January 1, 1992

Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid miceS Kamel-Reid, J E Dick, A Greaves, et al.

British Journal of Haematology|March 1, 1991

Fanconi's anaemia and pregnancyB P Alter, C L Frissora, D S Halpérin, et al.

Medical and Pediatric Oncology|January 1, 1992

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study GroupS A Feig, M D Krailo, R E Harris, et al.

Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:

Pageof 16

Blood|February 9, 1999

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approachJ Dimitroulakos, D Nohynek, K L Backway, et al.

Cancer Research|January 1, 1995

Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell linesG A Brown, J P McPherson, L Gu, et al.

Blood|December 1, 1996

Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disordersD K Miles, M H Freedman, K Stephens, et al.

Science (New York, N.Y.)|December 22, 1989

A model of human acute lymphoblastic leukemia in immune-deficient SCID miceS Kamel-Reid, M Letarte, C Sirard, et al.

Blood|September 1, 1996

Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot studyW R Rackoff, A Orazi, C A Robinson, et al.

Cancer Research|June 26, 1999

Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.

Blood|December 1, 1991

Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid miceS Kamel-Reid, M Letarte, M Doedens, et al.

Leukemia|January 1, 1992

Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid miceS Kamel-Reid, J E Dick, A Greaves, et al.

British Journal of Haematology|March 1, 1991

Fanconi's anaemia and pregnancyB P Alter, C L Frissora, D S Halpérin, et al.

Medical and Pediatric Oncology|January 1, 1992

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study GroupS A Feig, M D Krailo, R E Harris, et al.

Pageof 16